A small technical team building non-invasive diagnostics, backed by clinical leadership across tertiary care, district public health, and US infectious-disease academic medicine.
Leads AI/ML architecture, clinical study design, and regulatory strategy (CDSCO, FDA). Built SamaClip's optical stack and led the n=175 validation study at Anubhav Life Care for non-invasive, skin-tone-agnostic haemoglobin tracking.
Patent pending on the Tonsiliscope, a 3D-printed oropharyngeal imaging device for remote ENT exams. Research Scientist III at Boston Scientific (precision diagnostics), ML algorithm development on Medtronic's NIM Vital nerve-monitoring system, and AI/ML at Restor3d. Leads hardware, PCB, and cartridge design.
pdesai.vercel.app →
Infectious-disease physician-scientist with an active LA practice. Internal Medicine residency at UW, UCLA postdoc, and co-discoverer of diversity-generating retroelements (Nature). Advises on host-pathogen biology and infectious-disease workflow.
FNAC expert with 28+ publications and TB-relevant work distinguishing intestinal TB from Crohn's (a circulating miRNA + chemokine panel, Scientific Reports 2021) and on pulmonary-TB drug-resistance correlates. Principal investigator on the SamaBeat clinical validation study.
Owns diagnostic interpretation at our validation site and runs cartridge-readout cross-validation against gold-standard methods.
Based in North 24 Parganas, one of India's most populous districts (~10M). Direct exposure to high-volume TB workflow, AFB / GeneXpert routine, and pediatric and extra-pulmonary TB referrals from across the district.
Frugal, frontier engineering, paired with clinical leadership anchored in tertiary care (IPGMER / SSKM), district public health (Barasat GMCH), and US infectious-disease academic medicine.
We work with health systems, funders, researchers and community partners across India.